News | February 13, 2015

Shimadzu Announces First U.S. Trinias Digital Angiography System Installation

Crossover system designed to perform vascular and/or cardiac interventional exams

Shimadzu, Trinias C-12, First Coast Heart, angiography system, cath lab

February 13, 2015 — Shimadzu Medical Systems announced the first United States installation of its Trinias C-12 crossover system at First Coast Heart & Vascular Center in Jacksonville, Fla. This first North American installation of the Trinias angiographic system was completed by Shimadzu dealer/partner CMS Imaging of North Charleston, SC and began operation at the medical center in late January.

The Trinias 12 family of digital angiography systems (ceiling and floor mounts), which received U.S. Food and Drug Administration (FDA) 510(k) clearance in 2014, are designed as a crossover room to perform both vascular and/or cardiac interventional examinations. At First Coast Heart & Vascular Center, the ceiling mounted Trinias C-12 has been equipped with a 58-inch Eizo 8MP display monitor and a Mennen Hemodynamic system.

Patient safety is at the forefront of the system, with seven radiation dose reduction features to produce high-quality images with a minimum of radiation dose exposure. Its Score Pro imaging processing technology enhances fluoroscopic images and provides multiple specialized functions to expedite exam procedures.

First Coast Heart & Vascular Center provides a wide range of cardiac services at eight facilities in three northeast Florida counties.

For more information: www.shimadzu.com

Related Content

News | Cath Lab | February 23, 2018
February 23, 2018 — CorFlow Therapeutics AG announced that the company will present new insights into the coronary mi
Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Overlay Init